Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma
Gespeichert in:
| Veröffentlicht in: | Blood Advances Jg. 6; H. 12; S. 3606 - 3610 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Elsevier Inc
28.06.2022
American Society of Hematology |
| Schlagworte: | |
| ISSN: | 2473-9529, 2473-9537, 2473-9537 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Author | Bonifazi, Francesca Villacampa, Guillermo Lopez-Corral, Lucia Bramanti, Stefania Kersten, Marie José Chiappella, Annalisa Iacoboni, Gloria Rejeski, Kai Subklewe, Marion Martin Garcia-Sancho, Alejandro van Doesum, Jaap A. Schmidt, Christian Corradini, Paolo Kwon, Mi Zinzani, Pier Luigi Camacho-Arteaga, Lina van Meerten, Tom Marín-Niebla, Ana Reguera-Ortega, Juan Luis van Aalderen, Michiel Martínez-Cibrian, Nuria Barba, Pere |
|---|---|
| Author_xml | – sequence: 1 givenname: Gloria orcidid: 0000-0003-0805-9288 surname: Iacoboni fullname: Iacoboni, Gloria email: giacoboni@vhio.net organization: Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain – sequence: 2 givenname: Kai surname: Rejeski fullname: Rejeski, Kai organization: Department of Medicine III, University Hospital, LMU Munich, Munich, Germany – sequence: 3 givenname: Guillermo orcidid: 0000-0003-4868-6585 surname: Villacampa fullname: Villacampa, Guillermo organization: Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain – sequence: 4 givenname: Jaap A. orcidid: 0000-0003-0214-3219 surname: van Doesum fullname: van Doesum, Jaap A. organization: Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands – sequence: 5 givenname: Annalisa orcidid: 0000-0002-2977-0098 surname: Chiappella fullname: Chiappella, Annalisa organization: Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy – sequence: 6 givenname: Francesca surname: Bonifazi fullname: Bonifazi, Francesca organization: IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy – sequence: 7 givenname: Lucia orcidid: 0000-0003-1908-5596 surname: Lopez-Corral fullname: Lopez-Corral, Lucia organization: Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain – sequence: 8 givenname: Michiel surname: van Aalderen fullname: van Aalderen, Michiel organization: Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands – sequence: 9 givenname: Mi surname: Kwon fullname: Kwon, Mi organization: Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain – sequence: 10 givenname: Nuria surname: Martínez-Cibrian fullname: Martínez-Cibrian, Nuria organization: Department of Hematology, Hospital Clinic, Barcelona, Spain – sequence: 11 givenname: Stefania surname: Bramanti fullname: Bramanti, Stefania organization: Istituto Clinico Humanitas IRCCS, Rozzano, Italy – sequence: 12 givenname: Juan Luis surname: Reguera-Ortega fullname: Reguera-Ortega, Juan Luis organization: Department of Hematology, University Hospital Virgen del Rocio, Sevilla, Spain – sequence: 13 givenname: Lina orcidid: 0000-0001-9609-0394 surname: Camacho-Arteaga fullname: Camacho-Arteaga, Lina organization: Clinical Pharmacology Department, Vall d'Hebron University Hospital, Barcelona, Spain – sequence: 14 givenname: Christian surname: Schmidt fullname: Schmidt, Christian organization: Department of Medicine III, University Hospital, LMU Munich, Munich, Germany – sequence: 15 givenname: Ana surname: Marín-Niebla fullname: Marín-Niebla, Ana organization: Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain – sequence: 16 givenname: Marie José surname: Kersten fullname: Kersten, Marie José organization: Department of Hematology, Amsterdam University Medical Centers, Cancer Center Amsterdam, LYMMCARE (Lymphoma and Myeloma Center Amsterdam), Amsterdam, The Netherlands – sequence: 17 givenname: Alejandro orcidid: 0000-0001-6330-1028 surname: Martin Garcia-Sancho fullname: Martin Garcia-Sancho, Alejandro organization: Hematology Department, Hospital Clínico Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain – sequence: 18 givenname: Pier Luigi orcidid: 0000-0002-2112-2651 surname: Zinzani fullname: Zinzani, Pier Luigi organization: IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seràgnoli”, Bologna, Italy – sequence: 19 givenname: Paolo surname: Corradini fullname: Corradini, Paolo organization: Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy – sequence: 20 givenname: Tom surname: van Meerten fullname: van Meerten, Tom organization: Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands – sequence: 21 givenname: Marion orcidid: 0000-0003-3905-0251 surname: Subklewe fullname: Subklewe, Marion organization: Department of Medicine III, University Hospital, LMU Munich, Munich, Germany – sequence: 22 givenname: Pere surname: Barba fullname: Barba, Pere organization: Department of Hematology, Vall d'Hebron University Hospital, Experimental Hematology, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain |
| BackLink | https://cir.nii.ac.jp/crid/1872553967893867264$$DView record in CiNii https://www.ncbi.nlm.nih.gov/pubmed/35271707$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNkUtv1TAQhSNURB_0LyAvWLBJ8SO2kw2CVhSQKiEhWFt-TKjBiW9t58L99zi6LYiu7sZjyd-cM55z2hzNcYamQQRfENLT1ybE6LTb6tlCvqCYEozFQOmT5oR2krUDZ_Lo750Ox815zj8wxkQKxgf6rDlmnEoisTxp7r6ADu2vmIJDsPUOqiiKIzIJfi9Wm6K_wwxILyUGWCwENMaEyi2gkkCXCeay4gmC3mRwqD4mGJO2JaYdmvRcAqDaFlDYTZvbOOnnzdNRhwzn9_Ws-Xb9_uvVx_bm84dPV-9uWssJLi3n4wCYmIESa0Ytbc87zDg3DgYpaDdSITnUSggfwQiqeW-wcdwNnbE9sLPm1V53k-LdArmoyed1Ej1DXLKigvWSMiZ4RV_co4uZwKlN8pNOO_Wwpgq82QM2xZzrB5X1RRcf55K0D4pgtUaj_otG_YumCvSPBB48Dmh9uW-dva-260nq4JyzQch-YL2QVHQVu9xjUHe69ZBUtn5N0_kEtigX_SFebx-J2FAdrQ4_YXeYxB-h89Ev |
| CitedBy_id | crossref_primary_10_1158_2326_6066_CIR_22_0487 crossref_primary_10_1002_ajh_27056 crossref_primary_10_1182_bloodadvances_2023010364 crossref_primary_10_1111_bjh_18378 crossref_primary_10_1111_bjh_18697 crossref_primary_10_1002_hem3_87 crossref_primary_10_1182_bloodadvances_2021004535 crossref_primary_10_3389_fonc_2024_1407001 crossref_primary_10_1111_imj_16561 crossref_primary_10_1080_10428194_2024_2369653 crossref_primary_10_3389_fmed_2025_1553966 crossref_primary_10_1002_hon_3200 crossref_primary_10_1080_10428194_2023_2212098 crossref_primary_10_3390_cancers17132239 crossref_primary_10_1002_hon_70074 crossref_primary_10_1111_bjh_19617 crossref_primary_10_1016_j_csbj_2022_06_015 crossref_primary_10_3389_fimmu_2024_1519671 crossref_primary_10_3389_fonc_2024_1394057 crossref_primary_10_1186_s40164_024_00490_x crossref_primary_10_1002_jha2_655 crossref_primary_10_1111_bjh_19131 crossref_primary_10_3389_fimmu_2024_1435127 crossref_primary_10_1080_10428194_2023_2220456 crossref_primary_10_1016_j_ejca_2024_115145 crossref_primary_10_1080_10428194_2024_2338851 crossref_primary_10_1016_j_hoc_2023_07_002 crossref_primary_10_1038_s41571_024_00903_0 crossref_primary_10_1111_bjh_19961 crossref_primary_10_1001_jamanetworkopen_2024_61683 crossref_primary_10_1016_j_clml_2024_02_010 crossref_primary_10_1111_imj_16544 crossref_primary_10_3390_ijms24065688 crossref_primary_10_1097_HS9_0000000000000907 crossref_primary_10_3389_fonc_2022_925818 crossref_primary_10_1016_j_phrs_2024_107158 crossref_primary_10_1182_blood_2023022353 crossref_primary_10_1016_j_jcyt_2024_07_015 crossref_primary_10_1016_S2352_3026_22_00355_6 crossref_primary_10_1080_14737159_2024_2399152 crossref_primary_10_1080_21645515_2024_2378543 crossref_primary_10_1136_jitc_2024_009349 crossref_primary_10_1182_blood_2023020578 crossref_primary_10_1080_13543784_2025_2472410 crossref_primary_10_1080_10428194_2024_2320833 crossref_primary_10_1016_j_critrevonc_2023_104085 crossref_primary_10_1177_20406207221142133 crossref_primary_10_3389_fphar_2023_1200808 crossref_primary_10_3390_cancers15174253 crossref_primary_10_1007_s11899_023_00687_7 crossref_primary_10_1038_s41591_024_03084_6 crossref_primary_10_1080_10428194_2023_2227748 crossref_primary_10_3390_biomedicines10081960 |
| Cites_doi | 10.1056/NEJMoa1914347 10.1002/cam4.3881 10.1002/ajh.26233 10.1016/j.bbmt.2018.12.758 10.1200/JCO.2013.54.8800 10.1200/JCO.19.02104 10.1182/bloodadvances.2020003092 10.1200/JCO.19.02103 |
| ContentType | Journal Article |
| Contributor | Vall d'Hebron Barcelona Hospital Campus [Iacoboni G, Marín-Niebla A, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rejeski K] Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. [Villacampa G] Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. The Institute of Cancer Research, London, United Kingdom. [van Doesum JA] Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. [Chiappella A] Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy. [Bonifazi F] IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Sera |
| Contributor_xml | – sequence: 1 fullname: Institut Català de la Salut – sequence: 2 fullname: [Iacoboni G, Marín-Niebla A, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Rejeski K] Department of Medicine III, University Hospital, LMU Munich, Munich, Germany. [Villacampa G] Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. SOLTI Breast Cancer Research Group, Barcelona, Spain. The Institute of Cancer Research, London, United Kingdom. [van Doesum JA] Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. [Chiappella A] Division of Hematology and Stem Cell Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Milano, Milano, Italy. [Bonifazi F] IRCCS Azienda Ospedaliero-Universitaria di Bologna Istituto di Ematologia “Seragnoli”, Bologna, Italy. [Camacho-Arteaga L] Servei de Farmacologia Clínica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Farmacologia Clínica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Farmacologia, Terapèutica i Toxicologia, Universitat Autònoma de Barcelona, Bellaterra, Spain – sequence: 3 fullname: Vall d'Hebron Barcelona Hospital Campus |
| Copyright | 2022 The American Society of Hematology |
| Copyright_xml | – notice: 2022 The American Society of Hematology |
| DBID | 6I. AAFTH RYH AAYXX CITATION NPM 7X8 |
| DOI | 10.1182/bloodadvances.2021006922 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CiNii Complete CrossRef PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2473-9537 |
| EndPage | 3610 |
| ExternalDocumentID | 35271707 10_1182_bloodadvances_2021006922 S2473952922001616 |
| Genre | Journal Article |
| GroupedDBID | .1- .FO 0R~ 53G AALRI AAXUO AAYWO ACVFH ADCNI ADVLN AEUPX AFPUW AFRHN AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ EBS FDB GROUPED_DOAJ H13 HYE OK1 ROL RPM THE W2D Z5R 6I. AAFTH AFCTW RYH AAYXX CITATION NPM 7X8 |
| ID | FETCH-LOGICAL-c510t-55f9e01b921cbfa7c8540355bde97624f2675e24f115feb62a58b0bd5d94bc8e3 |
| ISICitedReferencesCount | 65 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000836434600006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2473-9529 2473-9537 |
| IngestDate | Fri Sep 05 06:37:40 EDT 2025 Thu Jan 02 22:55:03 EST 2025 Sat Nov 29 03:31:39 EST 2025 Tue Nov 18 21:42:12 EST 2025 Mon Nov 10 09:05:48 EST 2025 Thu Jul 20 20:10:09 EDT 2023 Tue Aug 26 16:31:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c510t-55f9e01b921cbfa7c8540355bde97624f2675e24f115feb62a58b0bd5d94bc8e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-2977-0098 0000-0003-0805-9288 0000-0001-6330-1028 0000-0003-0214-3219 0000-0003-3905-0251 0000-0003-1908-5596 0000-0003-4868-6585 0000-0001-9609-0394 0000-0002-2112-2651 0000-0002-4117-7991 |
| OpenAccessLink | http://dx.doi.org/10.1182/bloodadvances.2021006922 |
| PMID | 35271707 |
| PQID | 2638723365 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | proquest_miscellaneous_2638723365 pubmed_primary_35271707 crossref_citationtrail_10_1182_bloodadvances_2021006922 crossref_primary_10_1182_bloodadvances_2021006922 nii_cinii_1872553967893867264 elsevier_sciencedirect_doi_10_1182_bloodadvances_2021006922 elsevier_clinicalkey_doi_10_1182_bloodadvances_2021006922 |
| PublicationCentury | 2000 |
| PublicationDate | 2022-06-28 |
| PublicationDateYYYYMMDD | 2022-06-28 |
| PublicationDate_xml | – month: 06 year: 2022 text: 2022-06-28 day: 28 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Blood Advances |
| PublicationTitleAlternate | Blood Adv |
| PublicationYear | 2022 |
| Publisher | Elsevier Inc American Society of Hematology |
| Publisher_xml | – name: Elsevier Inc – name: American Society of Hematology |
| References | Wang, Munoz, Goy (bib1) 2020; 382 Iacoboni, Villacampa, Martinez-Cibrian, GETH, GELTAMO Spanish Groups (bib8) 2021; 10 Khurana, Dalland, Young, Inwards, Paludo (bib2) 2021; 96 Pasquini, Hu, Curran (bib7) 2020; 4 Lee, Santomasso, Locke (bib3) 2019; 25 Cheson, Fisher, Barrington, United Kingdom National Cancer Research Institute (bib4) 2014; 32 Jacobson, Hunter, Redd (bib6) 2020; 38 Nastoupil, Jain, Feng (bib5) 2020; 38 Cheson (2022062015231013200_B4) 2014; 32 Jacobson (2022062015231013200_B6) 2020; 38 Nastoupil (2022062015231013200_B5) 2020; 38 Lee (2022062015231013200_B3) 2019; 25 Pasquini (2022062015231013200_B7) 2020; 4 Khurana (2022062015231013200_B2) 2021; 96 Iacoboni (2022062015231013200_B8) 2021; 10 Wang (2022062015231013200_B1) 2020; 382 |
| References_xml | – volume: 25 start-page: 625 year: 2019 end-page: 638 ident: bib3 article-title: ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells publication-title: Biol Blood Marrow Transplant. – volume: 382 start-page: 1331 year: 2020 end-page: 1342 ident: bib1 article-title: KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma publication-title: N Engl J Med. – volume: 38 start-page: 3095 year: 2020 end-page: 3106 ident: bib6 article-title: Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity publication-title: J Clin Oncol. – volume: 32 start-page: 3059 year: 2014 end-page: 3068 ident: bib4 article-title: Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification publication-title: J Clin Oncol. – volume: 4 start-page: 5414 year: 2020 end-page: 5424 ident: bib7 article-title: Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma [published correction appears in publication-title: Blood Adv. – volume: 96 start-page: E298 year: 2021 end-page: E301 ident: bib2 article-title: Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis publication-title: Am J Hematol. – volume: 10 start-page: 3214 year: 2021 end-page: 3223 ident: bib8 article-title: Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma publication-title: Cancer Med. – volume: 38 start-page: 3119 year: 2020 end-page: 3128 ident: bib5 article-title: Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium publication-title: J Clin Oncol. – volume: 382 start-page: 1331 issue: 14 year: 2020 ident: 2022062015231013200_B1 article-title: KTE-X19 CAR T-cell therapy in relapsed or refractory mantle-cell lymphoma publication-title: N Engl J Med. doi: 10.1056/NEJMoa1914347 – volume: 10 start-page: 3214 issue: 10 year: 2021 ident: 2022062015231013200_B8 article-title: Real-world evidence of tisagenlecleucel for the treatment of relapsed or refractory large B-cell lymphoma publication-title: Cancer Med. doi: 10.1002/cam4.3881 – volume: 96 start-page: E298 issue: 8 year: 2021 ident: 2022062015231013200_B2 article-title: Brexucabtagene autoleucel therapy induces complete remission in a primary refractory blastoid mantle cell lymphoma with neurolymphomatosis publication-title: Am J Hematol. doi: 10.1002/ajh.26233 – volume: 25 start-page: 625 issue: 4 year: 2019 ident: 2022062015231013200_B3 article-title: ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells publication-title: Biol Blood Marrow Transplant. doi: 10.1016/j.bbmt.2018.12.758 – volume: 32 start-page: 3059 issue: 27 year: 2014 ident: 2022062015231013200_B4 article-title: Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification publication-title: J Clin Oncol. doi: 10.1200/JCO.2013.54.8800 – volume: 38 start-page: 3119 issue: 27 year: 2020 ident: 2022062015231013200_B5 article-title: Standard-of-care axicabtagene ciloleucel for relapsed or refractory large B-cell lymphoma: results from the US Lymphoma CAR T Consortium publication-title: J Clin Oncol. doi: 10.1200/JCO.19.02104 – volume: 4 start-page: 5414 issue: 21 year: 2020 ident: 2022062015231013200_B7 article-title: Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma publication-title: Blood Adv. doi: 10.1182/bloodadvances.2020003092 – volume: 38 start-page: 3095 issue: 27 year: 2020 ident: 2022062015231013200_B6 article-title: Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity publication-title: J Clin Oncol. doi: 10.1200/JCO.19.02103 |
| SSID | ssj0001763592 ssib053239758 |
| Score | 2.458551 |
| SourceID | proquest pubmed crossref nii elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3606 |
| SubjectTerms | Adult Antineoplastic Agents Humans Immunotherapy, Adoptive Investigative Techniques::Immunologic Techniques::Immunization::Immunization, Passive::Adoptive Transfer::Immunotherapy, Adoptive [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT] Limfomes - Tractament Lymphoma, Mantle-Cell neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células del manto [ENFERMEDADES] Neoplasm Recurrence, Local Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, Mantle-Cell [DISEASES] Other subheadings::Other subheadings::/drug therapy [Other subheadings] Otros calificadores::Otros calificadores::/farmacoterapia [Otros calificadores] Pyrimidines Real-world, brexucabtagene autoleucel, relapsed refractory, mantle cell lymphoma Receptors, Chimeric Antigen Research Letter Teràpia cel·lular técnicas de investigación::técnicas inmunológicas::inmunización::inmunización pasiva::transferencia adoptiva::inmunoterapia adoptiva [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS] |
| Title | Real-world evidence of brexucabtagene autoleucel for the treatment of relapsed or refractory mantle cell lymphoma |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S2473952922001616 https://dx.doi.org/10.1182/bloodadvances.2021006922 https://cir.nii.ac.jp/crid/1872553967893867264 https://www.ncbi.nlm.nih.gov/pubmed/35271707 https://www.proquest.com/docview/2638723365 |
| Volume | 6 |
| WOSCitedRecordID | wos000836434600006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2473-9537 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0001763592 issn: 2473-9529 databaseCode: DOA dateStart: 20160101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2473-9537 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib053239758 issn: 2473-9529 databaseCode: M~E dateStart: 20160101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Jj9MwFLbagQMXBGIrMCMjcasyJE68RJxGMIh1hGAY9RbZjiMVhaR0GXUu_Bx-J89OnLSgSkWIi1slsbO8L37fc96C0NOQ6CSRzARccxkkuQoDKXIVhIYnikoSKVc64eI9PzsTk0n6cTD46WNhLkteVWK9Tmf_VdSwDYRtQ2f_QtzdoLAB_oPQoQWxQ7uX4D8B9QtcItSxaUuGWkYIpu96paVawgQCxFKulnVpQK5l52jY-5zD4TbGZbYANgo7QYnOXVmeK-vsCucY2-X-cXkFSKjbed1_F7Z-8N6xoKPrb2DaVbUrHmXdOxrP5uY7j_lq2srZ7-TUb72wpZC0TQXpeqxcvOK32u-2IVcva7NoSjS_lXI2PjneXL4AyzdkPhzcran5uJott0-S8DhIabsW0s7TbBOOZGPSjVnINhR4zBpH2T-Vg7DJZl1AgH8Ox8TavCFLm-Do31Jvf7bXYS-DEEeN2RBdI5ymYsN0d2t5Nqufq7_dXbh3GhPk2a4T7mJCw2o63W3vON5zfgvdbA0WfNIA7TYamOoO-t6DDHuQ4brA2yDDPcgwgAwDyHAHMnu4BxmGnT3IcAMybEGGPcjuoi-vTs9fvA7a4h2Bhml-GVBapCaMVEoirQrJtQDbAMityg0wYJIUBExVA79gkhRGMSKpUKHKaZ4mSgsT30MHVV2ZBwiD2pG0ULpQSZjohCppIh0WDMbgmuVshLh_kJluM9vbAitl5ixcQbItEWS9CEYo6nrOmuwue_RJvawyH70M-jYDlO3R93nXt2W4DXPds_chQANu0baR4ITSOAWymcaCcTBsRuiJB00GSsJKSVamXsEYoGU5iWNGR-h-g6bufsEC4xEP-cN_uK9H6Eb_bj9GB8v5yhyi6_pyOV3Mj9CQT8SRe2Wg_fDj9BfNZfRb |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Real-world+evidence+of+brexucabtagene+autoleucel+for+the+treatment+of+relapsed+or+refractory+mantle+cell+lymphoma&rft.jtitle=Blood+advances&rft.au=Iacoboni%2C+Gloria&rft.au=Rejeski%2C+Kai&rft.au=Villacampa%2C+Guillermo&rft.au=van+Doesum%2C+Jaap+A.&rft.date=2022-06-28&rft.pub=Elsevier+Inc&rft.issn=2473-9529&rft.volume=6&rft.issue=12&rft.spage=3606&rft.epage=3610&rft_id=info:doi/10.1182%2Fbloodadvances.2021006922&rft.externalDocID=S2473952922001616 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2473-9529&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2473-9529&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2473-9529&client=summon |